Inflammatory cytokines have been implicated in the pathogenesis of rhe
umatoid arthritis (RA). To investigate the role of interleukin-l (IL-1
) and tumor necrosis factor alpha (TNF alpha) in arthritic processes w
e studied the effect of neutralizing antibodies against murine IL-1 an
d TNF alpha in murine collagen-induced arthritis (CIA). Combined i.p.
injection of anti-IL-1 alpha and anti-IL-1 beta (anti-IL-1 alpha,beta)
, given before onset of the disease, completely prevented CIA, In cont
rast, treatment with anti-TNF alpha at this time point only delayed th
e onset of arthritis. Remarkably, a single injection of anti-IL-1 alph
a,beta was also highly effective in suppressing established arthritis,
reducing both inflammation and cartilage destruction. Suppression was
most pronounced with the combination of anti-IL-1 alpha and beta, but
anti-IL-1 beta alone also gave significant relief. Specific antibodie
s against TNF alpha had no effect on established CIA. Of interest, ant
i-IL-1 alpha,beta treatment started after onset of CIA completely norm
alized chondrocyte synthetic function, which was highly suppressed in
the non-treated group. It is concluded that IL-1 and TNF alpha are imp
ortant cytokines during the onset of CIA and that IL-1 is the key medi
ator of inflammation and cartilage damage in established CIA.